Hugel (145020) Q3 2024 earnings summary

Executive summary

• Net sales reached KRW 105.1bn in 3Q24, up 23.9% year-over-year.

• Operating profit rose to KRW 53.4bn, a 54.5% increase year-over-year.

• Net income was KRW 42.0bn, up 1.1% compared to the same quarter last year.

Financial highlights

• Gross profit increased to KRW 82.9bn, up 25.2% year-over-year, with gross margin at 78.8%.

• SG&A expenses decreased 6.9% year-over-year to KRW 29.5bn.

• Pre-tax income was KRW 53.0bn, down 1.2% year-over-year.

Segment performance

• Toxin product sales grew 40.9% year-over-year to KRW 64.7bn.

• Filler sales declined 4.4% year-over-year to KRW 29.9bn.

• Cosmetics sales rose 37.4% year-over-year to KRW 9.0bn.

• Thread sales increased 37.9% year-over-year to KRW 1.5bn.

• International sales for Toxin & Filler rose 37.6% year-over-year to KRW 65.3bn, while domestic sales declined 1.4%.